top of page

New Pneumococcal Vaccine Available from 1 July 2026 – What You Need to Know

  • Writer: ERD
    ERD
  • Jun 5
  • 2 min read

Updated: Jun 14

From 1 July 2026, important changes are being made to Australia's pneumococcal vaccination program for adults.


The National Immunisation Program (NIP) is introducing a newer pneumococcal vaccine called Capvaxive® (21-valent pneumococcal conjugate vaccine), which will be available free of charge for eligible Australians aged 65 years and over. This new vaccine replaces the previous adult pneumococcal vaccines used under the NIP and is designed to protect against more strains of pneumococcal disease.


What is Pneumococcal Disease?

Pneumococcal disease is caused by the bacterium Streptococcus pneumoniae. It can lead to serious infections including:

  • Pneumonia (lung infection)

  • Bloodstream infections (sepsis)

  • Meningitis (infection around the brain and spinal cord)

Older adults are at increased risk of severe illness and complications from these infections.


Who Is Eligible?

From 1 July 2026, a single dose of the new pneumococcal vaccine is recommended and funded for:


  • Adults aged 65 years and over

  • Aboriginal and Torres Strait Islander adults aged 25 years and over

  • Adults aged 18 years and over with certain medical conditions that increase their risk of severe pneumococcal disease.


I've Had a Pneumococcal Vaccine Before – Do I Need Another One?


Possibly.


Many people previously received Pneumovax 23® or Prevenar 13®. Under the updated recommendations, eligible adults who have received a pneumococcal vaccine in the past may still benefit from the new vaccine, provided it has been at least 12 months since their last pneumococcal vaccination.


Your doctor can review your immunisation history and advise whether an additional dose is recommended for you.


Why the Change?

The new vaccine:

  • Covers more strains of pneumococcal bacteria

  • Simplifies the adult vaccination schedule

  • Expands protection against serious pneumococcal disease

  • Lowers the age for routine vaccination eligibility from 70 years to 65 years.


Should I Book In?

If you are aged 65 years or over, now is a great time to discuss your vaccination status with your GP. This could be done via a phone call first.


It is recommended you book in from the second week of July onwards.


Vaccination remains one of the most effective ways to reduce the risk of serious illness, hospitalisation and complications from pneumococcal disease.


Contact our reception team to book an appointment and review your eligibility for this important update to the National Immunisation Program.


Disclaimer: This article provides general health information only and is not intended as personal medical advice. Vaccination recommendations may vary depending on your age, medical history, previous vaccinations and individual circumstances. Please speak with your doctor for advice specific to your situation.

Comments


Commenting on this post isn't available anymore. Contact the site owner for more info.
Contact Us
3 Sager Place, East Ryde NSW 2113

P: 02 9888 1083
F: 02 9888 9585
 
EDI: estrmedp

Email: Due to security and privacy reasons we do not accept communication related to a patients clincial history.

Mon - Fri     8.30am - 5.00pm
Sat
                9.00am - 11.00am

Sun               Closed

East Ryde Doctors acknowledge the Traditional Owners and Custodians of the land on which we stand today, the Wallumedegal Clam of the Darug nation, and pay our respects to their Elders past, presents and emerging. We recognise the ongoing connection that Indigenous peoples have to the land and the importance of their cultural heritage to the community.

  • Instagram
  • Facebook

All content © 2026 East Ryde Doctors. All Rights Reserved | Privacy Policy | Terms & Conditions | Cancellation Policy
bottom of page